Abbott Biotech Ventures, Inc. (ABVI) is a subsidiary of Abbott dedicated to making venture capital investments in emerging biotech and pharmaceutical companies.
| Company | Date | Round | Size | Participants |
| NeuroGenetic Pharmaceuticals | 1/12 | Venture Round | 1 | |
| AuraSense Therapeutics | 12/11 | Series B | $5.4M | 1 |
| Creabilis | 10/11 | Series B | $20M | 2 |